Patram 37,5 mg FC tablets.
PDF Leaflet Revision Date: 04 February 2026
Clinical Summary
Quick overview from the medicine insert
Indication
Management of moderate to moderately severe pain in adults.
Dosage (summary)
Adults: 1-2 tablets every 4-6 hours as needed, max 8 tablets/day.
Onset of Action / Duration
Onset: 30 mins, Duration: 6-8 hours
Special Populations
- Elderly (u226565 years)
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or lactation due to risks of respiratory depression in newborns.
Key Drug Interactions
- CNS depressants
- MAO inhibitors
- Warfarin
Contraindications
- Hypersensitivity to tramadol or paracetamol
- Severe hepatic impairment
- Respiratory depression
- Children <12 years
Common side effects
- Nausea
- Dizziness
- Somnolence
- Constipation
Counselling Points
- Do not exceed recommended dose.
- Avoid alcohol and CNS depressants.
- Seek immediate medical attention for signs of overdose.
Serious warnings
- Risk of seizures
- Potential for dependence and abuse
- Risk of respiratory depression
Important Disclaimer
The Patram 37,5 mg FC tablets. professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
